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Abstract
The hypotheses that PKCepsilon is necessary for: 1) PGF2alpha to inhibit LH-stimulated progesterone (P4)
secretion, and 2) for the expression of key prostaglandin synthesizing/metabolizing enzymes were tested
in bovine luteal cells in which PKCepsilon expression had been ablated using a validated siRNA protocol.
Steroidogenic cells from Day -6 bovine corpus luteum (CL) were isolated and transfected to reduce
PKCepsilon expression after 48, 72 and 96 h. A third tested hypothesis was that an increase in intracellular
calcium concentration ([Ca(2+)]i) is the cellular mechanism through which PGF2alpha inhibits luteal
progesterone. The hypothesis was tested with two pharmacological agents. In the first test, the dose-
dependent effects on raising the [Ca(2+)]i with the ionophore, A23187, on basal and LH-stimulated P4
secretion in cells collected from early (Day -4) and mid-cycle (Day -10) bovine CL was examined. In the
second test, the ability of PGF2alpha to inhibit LH-stimulated P4 secretion in Day-10 luteal cells was
examined under conditions in which an elevation in [Ca(2+)]i had been buffered by means of the
intracellular calcium chelator, Bapta-AM.
PKCepsilon expression was reduced 65 and 75% by 72 and 96 h after transfection, respectively. In cells in
which PKCepsilon expression was ablated by 75%, the inhibitory effect of PGF2alpha on LH-stimulated P4
secretion was only 29% lower than in the LH-stimulated group. In contrast, it was reduced by 75% in the
group where PKCepsilon expression had not been reduced (P < 0.05). Real time PCR analysis indicated
that there were no differences in the expression of cyclooxygenase-2 (COX-2), aldoketoreductase 1B5
(AKR1B5), prostaglandin E synthase (PGES), hydroxyprostaglandin-15 dehydrogenase (PGDH) and PGE2
-9-reductase as a function of PKCepsilon down-regulation. Finally, LH stimulated secretion of P4 at each
luteal stage (Day -4 and -10), and PGF2alpha inhibited this only in Day -10 cells (P < 0.05). When A23187
was used at concentrations greater than 0.1 µmol, the induced elevation in [Ca(2+)]i inhibited the effect
of LH on secretion of P4 in Day -4 and -10 cells (P < 0.05, Fig. 5). The inhibitory effect of PGF2alpha on
LH-stimulated P4 in Day -10 cells was reduced if an increase in [Ca(2+)]i was prevented with Bapta-AM.
These results support the hypothesis that differential expression of PKCepsilon and an elevation of
[Ca(2+)]i are important for acquisition of luteolytic response to PGF2alpha.
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Background
The corpus luteum (CL) is a transient endocrine gland
whose primary secretory product is progesterone (P4).
The life span of the CL and consequently the amount of
P4 it secretes is regulated according to reproductive phys-
iological status. Substances reducing P4 secretion and
shortening the luteal life span are said to be luteolytic
[1,2].
In most species, including human beings, PGF2α is recog-
nized as an important if not the main luteolytic factor [3-
9]. During the ovarian cycle, the transition from early to
mid-luteal phase is associated with changes in resistance/
susceptibility to the luteolysin PGF2α; in cows, the CL is
resistant to exogenous PGF2α prior to day 5 of the estrous
cycle [10-17]. The cellular basis controlling luteal func-
tion during these physiological transitions, although stud-
ied intensely, is incompletely understood.
In steroidogenic cells of the ruminant CL, PGF2α activates
its plasma membrane G-protein-coupled receptor, which
in turn activates the membrane-bound phosphoinositide-
specific phospholipase C (PLC), yielding inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol [18]. Indeed, in
bovine luteal cells, PGF2α stimulated phosphatidylinosi-
tol 4,5-biphosphate hydrolysis and mobilized intracellu-
lar Ca2+ [19]. Accordingly, calcium and protein kinase C
(PKC) have been shown to be the intracellular mediators
of PGF2β actions in luteal cells [20]. The regulatory effects
of intracellular calcium concentration ([Ca2+]i) on proges-
terone might be biphasic as there is also evidence for a cal-
cium requirement to support P4 synthesis by bovine
luteal cells and LH, a luteotrophic hormone, increases IP3,
and [Ca2+]i in bovine luteal cells and in porcine granulosa
cells [21-23]. Therefore, there might exist thresholds of
[Ca2+]i that support or inhibit P4 synthesis.
Choudhary et al, [17] tested the ability of increasing con-
centrations of PGF2α to increase the [Ca2+]i in large (LLC)
and small (SLC) bovine luteal cells as function of develop-
ment. Day-10 steroidogenic cells were more responsive to
PGF2α than Day-4 cell. Response amplitudes and number
of responding cells were significantly affected by agonist
concentration, luteal development and cell type.
Response amplitudes were greater in LLC than in SLC;
responses of maximal amplitude were elicited with lower
agonist concentrations from Day-10 than from Day -4
cells. Furthermore, on Day-10, as concentrations of
PGF2α increased, larger percentages of SLC responded.
Based on those results Choudhary et al proposed that the
lower efficacy of PGF2α in the early CL was likely related
to signal transduction differences associated with the
PGF2α receptor at those two developmental stages [17].
The array of PKC isozymes expressed in whole bovine CL
includes α, βI, βII, ε and µ[24-27]; and it has been dem-
onstrated that the amount of PKCε expressed in the Day-
10 CL is greater than in the Day-4 CL [26]. The latter
observation led Sen et al, to propose that differential
expression of PKCε as a function of development could
play a role in the observed transitional resistance/suscep-
tibility to PGF2α-induced luteal regression [26,27]. Sen et
al, had further hypothesized that regulation of [Ca2+]i was
a cellular mechanism through which PKCε could mediate
actions of PGF2α on P4 secretion [27]. Additionally, there
is evidence indicating that when bovine follicular theca
cells are isolated and their luteinization is induced under
in vitro tissue culture conditions, they express PKCδ [28].
As PKCδ has been reported to play an important role in
other species such as in rabbits and rodents [29,30], this
PKC isozyme might also be important for the physiology
of the bovine ovary.
Endothelial cells of the bovine CL do not express PKCε,
although they do express the other PKC isozymes
described in the bovine CL [31]. Data obtained with West-
ern blot and immunohistological assays indicated that
steroidogenic cells are the main source of PKCε in the
bovine CL [31]. Therefore, in experiment 1, in order to
assess the potential physiological role of PKCε, we have
used a siRNA strategy to down- regulate the expression of
this PKC isozyme in luteal steroidogenic cells. In experi-
ment 2, we used the PKCε down-regulated cells to test two
hypotheses. Our first working hypothesis was that PKCε
expression was necessary for PGF2α to inhibit LH-stimu-
lated P4 secretion in vitro. The second working hypothesis
was that PKCε was necessary for the expression of key
genes of prostaglandin synthesis/metabolism that would
favor PGF2α synthesis; whereas in PKCε down regulated
cells, the expression of key genes of prostaglandin synthe-
sis/metabolism would be such that synthesis of PGE2
would be favored. Finally, in experiment 3, we tested the
hypothesis that [Ca2+]i is the cellular mechanism through
which PGF2α inhibits luteal progesterone. We reasoned
that if a pharmacological treatment is used to increase
[Ca2+]i, this should inhibit luteal progesterone secretion
with equally effectiveness, regardless of the developmen-
tal stage of the CL. Therefore, we used a pharmacological
agent to increase [Ca2+]i and examine its effects on LH-
induced P4 secretion in luteal cells collected from early
(Day -4) and mid-cycle (Day -10) bovine CL. Further-
more, this hypothesis was also tested by using a pharma-
cological agent to buffer any increase in [Ca2+]i and
examine, under conditions of low [Ca2+]i, the anti-ster-
oidogenic effect of PGF2α on LH-induced P4 synthesis/
secretion in cultures of luteal cells collected from mid-
cycle (Day -10) CL.
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Methods
Tissue collection
Non-lactating beef (experiments 1 and 2) or dairy (exper-
iment 3) cows were observed visually for estrus twice daily
at approximately 12-h intervals for a minimum of 30 min
per observation. The day when standing estrus was
observed was designated as Day 0 [32]. For experiments 1
and 2, the CL from four beef cows on Day-6 of the estrous
cycle were collected in ice-cold saline and transported to
the laboratory for luteal cell dispersion as described
below. For experiment 3, 14 non-lactating dairy cows
were synchronized with 25 mg PGF2α analog (Lutalyse®;
Pfizer Animal Health., New York, NY) and ovaries on Day
-4 (n = 4) or CL on Day -10 (n = 10) were collected surgi-
cally as described below and transported to the laboratory
in ice-cold saline for dissociation and luteal cell enrich-
ment as described below. The surgical procedure was per-
formed via supravaginal incision under epidural
anesthesia. For the epidural anesthesia, 6–9 ml 2% lido-
caine were administered for cows weighing 450–700 kg
(Butler Company, Columbus, OH). After surgery, penicil-
lin (300,000 units) was administered intramuscularly to
protect against post-surgical infection. The CL or ovary
was collected into ice-cold phosphate buffered saline
(PBS) at pH 7.4 and transported to the laboratory within
15 to 30 min after collection. The Animal Care and Use
Committee of West Virginia University approved all pro-
cedures for these experiments (ACUC protocol # 06-
0401).
Luteal cell dispersion and purification
In the laboratory, the CL was dissected free of connective
tissue, weighed, placed into cell dispersion medium
(CDM, M-199 containing 0.1% BSA, 25 mM Hepes, 100
U/ml fungicide), and cut into small (about 1 mm3) frag-
ments. The tissue fragments were processed for tissue dis-
sociation as previously described [17]. Luteal endothelial
cells were separated by a procedure previously described
[17,33-35]. Briefly, magnetic tosylactivated beads (Dynal
Biotech, Lake Success, NY) were used to separate endothe-
lial cells and the non-adherent cells, steroidogenic-
enriched luteal cells) were collected [33-35]. The cell pop-
ulation designated as steroidogenic cells represented a
heterogeneous population of cells including fibroblasts,
pericytes, lymphoid and possibly few endothelial cells not
removed by the separation procedure. Cell viability and
density were determined using Trypan Blue exclusion and
a hemocytometer; luteal cell viability was usually greater
than 96%.
Experiment 1
Validation of siRNA methodology for specifically down-
regulating PKCε expression in enriched steroidogenic
luteal cells.
Day-6 dissociated luteal steroidogenic cells were cultured
overnight at a cell density of 1 × 106 cells/well in 35 mm
24 – well culture dishes (Corning Inc, Corning NY) con-
taining 1 ml Medium 199 supplemented with 5% fetal
calf serum (FCS, GIBCO) at 37°C (95% air, 5% CO2). The
next day cells were transiently transfected with PKCε-spe-
cific siRNA kit (Upstate Cell Signaling solutions, Lake
Placid NY) using lipofectin 2000 kit (Invitrogen Life Tech-
nologies) following the procedure recommended by the
manufacturer. After transfection for 4 hr, the cultures were
provided with M199 supplemented with 10% FCS, and
incubated for a total of 48, 72 or 96 hours. After each of
these time points, the cells were collected by adding 2 ml
M199 containing 0.25% trypsin (GIBCO) to cover the
monolayer and leaving the culture dish for about 1 min at
room temperature. The cells were aspirated and washed
one time with M199 containing 5%FCS and once with
M199 without FCS. Cells collected from duplicate wells
were pooled and the efficiency of transfection at 48, 72
and 96 h was analyzed by RT-PCR and Western blot anal-
ysis. Control groups included cells cultured in presence of
M199 alone, M199 and transfecting reagent, and cells
treated with non-specific siRNA duplex (non-specific
siRNA).
Experiment 2
Effects of down-regulating PKCε expression by the siRNA
protocol on: A) the ability of PGF2α to inhibit the LH-
stimulated P4 accumulation, and B) on the expression of
key genes involved in prostaglandin synthesis and metab-
olism.
Hypothesis 1: PKCε is necessary for PGF2α to be able to
inhibit P4 secretion. To examine the ability of PGF2α (Cay-
man Chemical, Ann Arbor, MI) to inhibit LH-induced
progesterone accumulation, the siRNA transfected and
control cells (not treated with PKCε siRNA) were treated,
after 96 h, with100 ng/ml of LH, 1000 ng/ml of PGF2α, or
a combination of LH and PGF2α for 4 hrs. After this time,
the cell free medium was collected from each treatment
and frozen until determination of P4 by radioimmu-
noassay (RIA). The RIA used for measurements of P4 in
the culture media has been described previously [36]. The
standard curve for this RIA ranged from 10 pg/ml to 800
pg/ml, and the intra- and interassay coefficients of varia-
tion were 9.2% and 12.8%, respectively.
Hypothesis 2: PKCε is necessary for the expression of key
prostaglandin biosynthetic/metabolizing enzymes. For
the real time quantitative determination of gene expres-
sion of key prostaglandin biosynthetic/metabolizing
enzymes in PKCε down-regulated and control (not down-
regulated) cells, RNA samples were obtained from the
cells collected in the experiment described under Hypoth-
esis 1. The genes examined were: aldoketoredutase 1B5
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(AKR1B5), prostaglandin-15 dehydrogenase (PGDH),
prostaglandin E synthase (PGES), prostaglandin E-2-9-
redutase, and cyclooxygenase-2 (COX-2). Enriched ster-
oidogenic cells were treated with the PKCε siRNA protocol
and after 96 h of culture the cells were treated with LH
(100 ng/ml), PGF2α (1000 ng/ml), or a combination of
LH and PGF2α for 4 h. The cells were collected by a brief
trypsin treatment and total RNA was isolated with Trizol
reagent according to the manufacturer's instructions
(GIBCO). Total RNA was quantified spectroscopically at
260 nm and integrity of the RNA was determined by 2%
agarose gel electrophoresis. Specific primers were
designed by using primer 3 software. The primer
sequences and their accession numbers are shown in table
1. The single-step RT-PCR was carried out and cDNA prod-
uct for each gene was column purified. Ten-fold serial
dilutions of cDNA for each of the genes were used as tem-
plates to generate standard curves. Total RNA samples
were reverse transcribed and used as templates in an iQ5
cycler (Bio-Rad Laboratories, Hercules, CA). The 25 µl
reaction mixture contained 12.5 µl SYBER green mix (Bio-
Rad Laboratories), 2 µl cDNA sample, 2.5 µl each sense
and antisense primers (0.5 µmol) and 5.5 µl of RNAse -
free H2O. The standard curves of threshold cycle (ct value)
versus log starting quantity for the genes of interest were
obtained. The conditions used were as follows: inactiva-
tion of RT enzyme, 95°C/3 min; denaturation, 95°C/30
sec; annealing, 55°C/30 sec; and extension, 72°C/1 min
with fluorescence acquisition. The melt-curves were gen-
erated from 55°C to 95°C with 0.5°C increments in tem-
perature. The melt-curves were observed for presence of
single amplification product. The slope and intercept val-
ues obtained from the standard curve were used to deter-
mine the starting quantity for each gene using linear
regression equation and gene expression for the desired
gene was normalized using β-actin as the reference gene.
Experiment 3
The working hypothesis was that a rise in [Ca2+]i is the cel-
lular mechanism through which PGF2α inhibits luteal P4.
Effect of a pharmacological increase in [Ca2+] i on the LH-
stimulated P4 synthesis/secretion in Day-4 and -10 luteal ster-
oidogenic cells. We predicted that if [Ca2+]i is increased by
a pharmacological treatment, this increase in [Ca2+]i
should be equally effective in reducing the LH-stimulated
P4 secretion regardless of the developmental stage of the
CL. The enriched steroidogenic cells (1 × 105 cells/well)
isolated from Day-10 and Day-4 CL of PGF2α-synchro-
nized non-lactating dairy cows were cultured overnight in
15 mm 24 -well culture plates in medium M199 supple-
mented with 0.1% BSA and 0.5% FCS. The next morning,
the cells were treated in duplicate wells for 24 hr with
M199 (control), LH (100 ng/ml), PGF2α, (1.0 µg/ml),
and a combination of LH and PGF2α. The ability of
increasing concentrations of the calcium ionophore,
A23187 (0.1, 1, 10, or 100 µmol, (Invitrogen Detection
Technologies), to inhibit basal and LH -stimulated P4
synthesis/secretion was tested in duplicate wells. The
medium for the control group contained 0.1% dimethyl-
sufoxide (DMSO, Pierce Rockport, IL), the solvent used
for PGF2α and A23187. The cell-free media were collected
and frozen until later measurements of P4 by RIA. The
concentrations of A23187 used were based on single-cell
studies, in which a concentration of 1 µmol A23187 was
usually effective in increasing [Ca2+]i to values compara-
ble to those seen when cells were stimulated with PGF2α
at a concentration of 1000 ng/ml. The concentration
range used of the Ca2+ ionophore should assure a very
good probability of eliciting a wide range in increases in
[Ca2+]i that would allow testing its effect on the LH-stim-
ulated P4 synthesis/secretion in Day-4 and -10 steroidog-
enic cells.
Table 1: Primer sequence, accession number, product size and annealing temperature of investigated genes










AKR1B5 F 5' GACCTTGGGTACCGTCACAT3'
R5'TCTTTCTCACTGGGAATCACG3'
S54973 150 59°C
PGE2 9- Reductase F 5'AAGAAATGCAGCCGTGAACT3'





• Actin was amplified under the same conditions as gene of interest
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If the PGF2α -stimulated increase in [Ca2+]i is prevented,
PGF2α T will not be able to inhibit P4 synthesis/secretion. This
experiment examined the ability of PGF2α to inhibit LH-
stimulated P4 secretion in Day-10 luteal cells under con-
ditions in which elevations in [Ca2+]i were buffered. This
was accomplished by testing the effect of 1,2-bis(2-ami-
nophenoxy)ethane-N, N, N', N'-teyracetic acid tetrakis
acetomethyl ester, Bapta-AM (Invitrogen Detection Tech-
nologies, Carlsbad, CA), an effective pharmacological
agent known to buffer changes in [Ca2+]i [37,38]. The
concentration range chosen, 0.1 to 1000 µmol, was based
on preliminary single-cell studies indicating that at the
concentration of 10 µmol, Bapta-AM effectively prevented
the typical increase in [Ca2+]i induced by PGF2 in luteal
steroidogenic cells. The enriched Day-10 steroidogenic
cells (1 × 105 cells/well) isolated as described above were
cultured overnight in 15 mm 24 -well culture plates in
medium M199 supplemented with 0.1% BSA and 0.5%
FCS. The next morning, the cells were treated in duplicate
wells for 24 hr with M199 (control), LH (100 ng/ml),
PGF2α, (1.0 µg/ml), and a combination of LH and PGF2α
with increasing concentration of Bapta-AM (0.1, 1, 10,
100 or 1000 µmol). The effect of each treatment on basal
and LH -stimulated P4 synthesis/secretion was tested in
duplicate wells. The medium for the control group con-
tained 0.1% dimethylsufoxide (DMSO, Pierce Rockport,
IL), the solvent used for PGF2α and Bapta. The cell-free
media were collected and frozen until later measurements
of P4 by RIA.
Semi-quantitative RT-PCR
The time-course effectiveness of the siRNA treatment in
down-regulating PKCε mRNA expression was determined
by a semi-quantitative RT-PCR procedure (RT-PCR, Qia-
gen, Valencia, CA) previously validated and described
[24]. In this RT-PCR assay, PKCε expression was normal-
ized to the expression of GAPDH as the reference gene.
The sequence of the PKCε and GAPDH primers were those
previously published: [17], sense 5'-AGCTT-
GAAGCCCACAGCCTG-3'; antisense 5'-CTTGT-
GGCCGTTGACCTGATG-3'; and (34), sense 5'-
TGTTCCAGTATGATTCCACCC-3'; antisense 5'- TGTTC-
CAGTATGATTCCACCC-3' respectively. The specificity for
these primer sets have been documented (17, 24), and
confirmed here by using the nucleotide database of
National Center for Biotechnology Information [39] with
BLAST software. The RT-PCR assay conditions were as fol-
lows: 50°C for 30min for reverse transcription reaction,
95°C for 15min for inactivation of RT enzyme, and then
for PCR cycles consisted of 95°C for 50seconds for dena-
turing, 58°C for 30seconds for annealing, 72°C for 1min
for extension and a final extension of 5min at 72°C. The
RT-PCR products were electrophoresed on 2% agarose gel
stained with ethidium bromide and viewed using the
Fluro-S MultiImager (Bio-Rad Laboratories). Data were
collected using densitometric analysis of Quantity One
quantification software package (Version 4, Bio-Rad Lab-
oratories). The intensity of the signal corresponding to
PKC isozyme was standardized by the corresponding
intensity of GAPDH control in that sample.
Semi-quantitative Western blots
Proteins were isolated from cells of siRNA treated and
control groups using previously described methodology
[24]. Details for the semi-quantitative Western blot proto-
col used here have been described elsewhere [26]. Briefly,
protein samples (10 µg/lane) were resolved on an 8%
polyacrylamide gel. The resolved proteins were transferred
to polyvinylidene fluoride membrane (Biotechnology
Systems, Boston, MA). The membranes were treated for
immunodetection of the proteins of interest. The follow-
ing primary antibodies were used: a mouse anti-actin
monoclonal antibody ([used at a dilution of 1:3000 (v/v]
Chemichon International, Inc., Temecula, CA); PKC iso-
zyme specific (α, βI, βII, ε,) polyclonal antibodies and
their antigenic peptides ([antibodies used at dilution
1:1000] Gibco, Grand Island, NY). The following horse-
radish peroxidase-conjugated secondary antibodies were
used here: anti-rabbit (1:5000, v/v; Amersham Pharmacia
Biotech, and anti-mouse (1:30,000 v/v; GIBCO). Densit-
ometry of the bands of interest were performed using
Quantity One quantitation software. The intensity of the
signal corresponding to the protein of interest was stand-
ardized by the corresponding intensity of the actin control
in that sample. This normalization of data allows an esti-
mate, in a semi quantitative manner, the amount of pro-
tein in the samples of interest, as described earlier [26].
Statistics
The statistical software program from Statistical Analysis
System, JMP 3.0 was used for data analyses [40]. Data
were expressed as means ± SEM for all the experiments.
One-way ANOVA was used to determine effects of differ-
ent treatments. Tukey – Kramer HSD was used to compare
the different treatments subgroups. A value of P < 0.05
was considered statistically significant.
Results
Experiment 1
Culturing steroidogenic cells collected from the Day -6 CL
spontaneously induced the expression of PKCε (data not
shown). Expression of PKCε was induced gradually by the
tissue culture conditions, and as Day-6 luteal cells were
cultured up to 6 days, PKCε expression had been sponta-
neously increased to values comparable to those seen in
Day-10 CL (data not shown).
Fig. 1A shows a typical result of the time-course siRNA
experiments performed. The summarized data shown in
Fig. 1B indicate that there was a significant (P < 0.05)
Reproductive Biology and Endocrinology 2007, 5:37 http://www.rbej.com/content/5/1/37
Page 6 of 13
(page number not for citation purposes)
decrease in the amounts of mRNA encoding PKCε after 72
h of transfection (0.36 ± 0.07) compared to the media-
treated control group (1.03 ± 0.05). Panels A and B in Fig.
1 show that this approach reduced PKCε expression 65
and 75% (0.23 ± 0.04) by 72 and 96 hrs of treatment
respectively. This reduction was specific because no simi-
lar changes were observed in treatments receiving only
experimental media (Media), receiving non-specific
siRNA duplexes (Non-Sp siRNA), or receiving only trans-
fection reagents (Transfection reagent, Fig. 1B).
The effectiveness of the siRNA transfection in reducing
protein corresponding to PKCε can be seen in the semi-
quantitative western blotting (Fig 2A). A visual reduction
in protein was detected 72 h after transfection (Fig. 2A).
However, the semi-quantitative analysis of the data indi-
cated that a significant reduction (P < 0.05) in the amount
of PKCε protein had not occurred until 96 h after transfec-
tion. At this time, there was a 50% reduction in the siRNA
-treated group (0.39 ± 0.02) compared to control group
(0.82 ± 0.07, Media, Fig. 2B). Figure 3 demonstrates the
specificity of the siRNA transfection in down-regulating
the PKCε isozyme. This Western blot was carried out for
other PKC isozymes, PKCα and PKCβ II, and there was no
reduction in the amounts of these isozyme proteins even
at 96 h after transfection with PKCε-specific siRNA; a time
by which there was significant reduction in PKCε (Fig.
2B).
Experiment 2
Hypothesis 1: Effect of PKCε down-regulation on the ability of
PGF2α to decrease the LH-induced P4 accumulation.
Enriched steroidogenic cells (n = 4) transfected with PKCε
siRNA were cultured for 96 h and treated with LH, PGF2α,
and combination of LH and PGF2α for 4 h. The control
group included cells treated with the hormones described
above, but expressing normal amount of PKCε. PKCε
down-regulation did not induce a decrease in the amount
of P4 accumulation in the LH-stimulated cells (158.4 ±
18.1) compared to the control (202.4 ± 11.4). As in previ-
ous experiments, the accumulation of P4 was significantly
reduced (P < 0.05) by PGF2α (42.9 ± 2.6) compared to LH
-treated control group (202.4 ± 11.4). There was no differ-
ence in the amounts of accumulated P4 between PGF2α-
treated PKCε down-regulated cells (34.9 ± 8.1) and con-
trol group (42.9 ± 2.6). However, the ability of PGF2α to
decrease LH-stimulated P4 accumulation was significantly
(P < 0.05) inhibited in the PKC ε down-regulated group,
124.4 ± 7.4 compared to control, 51.4 ± 4.1 (Fig. 4).
Hypothesis 2: Gene expression of key prostaglandin biosyn-
thetic/metabolizing enzymesin PKCε down-regulated cells.
Real-time PCR analysis of total RNA for mRNA encoding
Cox-2, AKR1B5, PGES, PGDH and PGE (2) -9-ketoreduct-
ase indicated that there were no significant differences in
the expression of any of these genes as a functions of PKCε
down-regulation, LH or PGF2α treatment (data not
shown).
Experiment 3
A rise in [Ca2+]i is the cellular mechanism through which
PGF2α inhibits luteal P4.
Effect of a pharmacological increase in [Ca2+]i on the LH-stim-
ulated P4 synthesis/secretion in Day-4 and -10 luteal steroidog-
enic cells. As reported in previous studies [17], basal P4
Time-course reduction in PKCε mRNA expression after transfection of luteal steroidogenic cells with PKCε sp cific siRNAF gur  1
Time-course reduction in PKCε mRNA expression after 
transfection of luteal steroidogenic cells with PKCε specific 
siRNA. (A) Representative RT-PCR products obtained from 
total RNA using the PKCε and GAPDH primers. The amount 
of total RNA was adjusted to 200 ng per reaction and 40 
cycles were used for PKCε ; while 28 cycles were used for 
GAPDH. The size of the amplified products for the GAPDH 
and PKCε were 900 and 500 bp, respectively. PKCε and 
GAPDH mRNA expression after 48, 72, and 96 h of transfec-
tion with PKCε specific siRNA are shown. Lanes labeled 
Media, non-specific (Non-sp) siRNA, and Transfection rea-
gent represent respective treatments without PKCε specific 
siRNA treatment. GAPDH was used as the control gene to 
normalize the PKCε mRNA expression. (B) Quantitative 
analysis of the RT-PCR products obtained in four (n = 4) rep-
licates similar to those shown in panel A. Data are the mean 
mean ± SEM of the densitometry measurements for PKCε 
relative to GAPDH mRNA. Statistical comparisons were 
made between different treatments. Different letters above 
each SEM represent different values (P < 0.05).
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accumulation in cells collected form Day -4 CL was signif-
icantly lower than in those collected from Day -10 (7.6 ±
2.2 and 29.2 ± 1.8 respectively, Fig. 5A and 5B). LH signif-
icantly increased (P < 0.05) the luteal progesterone accu-
mulation in both Day- 4 (49.5 ± 16.3) and -10 cells (65.7
± 3.7). This effect of LH was not inhibited by PGF2α in
Day- 4 cells (44.6 ± 17.5), whereas it was significantly
inhibited in Day-10 cells (31 ± 1.9, Fig. 5A and 5B). When
used at 0.1 µmol, A23187 did not reduce LH-stimulated
P4 accumulation in Day -4 or -10 cells; but at higher con-
centration (1.0 – 100 µmol), it negated the stimulatory
effect of LH on P4 (P < 0.05, Fig. 5A – B). Basal P4 accu-
mulation in Day -4 and -10 cells was not affected by any
concentrations of A23187 tested (Fig. 5A and 5B, only
100 µmol A23187 shown).
If the PGF2α -stimulated increase in [Ca2+]i is prevented,
PGF2α T will not be able to inhibit P4 secretion. LH signifi-
cantly increased (P < 0.05) the luteal progesterone accu-
mulation in Day- 10 cells (64.6 ± 3, Fig. 6). This effect of
LH was completely inhibited by PGF2α (21.1 ± 2.1, Fig.
6). Importantly, basal P4 accumulation (Fig. 6) was not
affected by the Bapta-AM treatment, not even the highest
concentration used (20.9 ± 4.1). When Bapta-AM was
used at 0.1, 1, 10 and 100 µmol in combination with LH,
the values on P4 accumulation became intermediate
between those observe for basal and LH alone (Fig. 6);
and the stimulatory effect of LH was completely elimi-
nated by 1000 µmol Bapta (data not shown). Conse-
quently, the effect of Bapta-AM on the anti-steroidogenic
action of PGF2α could only be tested up to 100 µmol. The
inhibitory effect of PGF2α on LH-stimulated luteal P4
Reduction in PKCε proteinFig re 2
Reduction in PKCε protein. (A) Representative Western blot showing the amount of PKCε and actin expressed in protein 
samples prepared from luteal steroidogenic cells after 48, 72, and 96 h of transfection with PKCε specific siRNA (lanes 1–3). 
Lanes labeled 4 – 6, contained protein samples from indicated control treatments (media, Non-sp siRNA, and transfection rea-
gent, respectively). (B) Semi-quantitative analysis of the densitometry derived from four experiments similar to the one shown 
in panel A. the y-axis shows the ratio of the optical density ratio of PKCε to that of its corresponding β-actin. The data are 
shown as mean ± SEM, and comparisons were made between different treatments. Values with different letters denote differ-
ences by one-way ANOVA followed by Tukey-Kramer honestly significant difference (P < 0.05).
Reproductive Biology and Endocrinology 2007, 5:37 http://www.rbej.com/content/5/1/37
Page 8 of 13
(page number not for citation purposes)
accumulation was not affected by Bapta when used at con-
centrations not exceeding 1 µmol, as the values for P4
accumulation clearly were not different from those
observed for basal values (P < 0.05, Fig. 6). However, at 10
and 100 µmol, Bapta-AM effectively reduced the ability of
PGF2α to inhibit the stimulatory effect of LH on P4 accu-
mulation (Fig. 6).
Discussion
The roles of specific PKC isozymes in luteal physiology
have received little attention to date. As discussed below,
these studies were designed to test the effects of ablating
PKCε expression in order to examine its hypothesized
function. Previous studies had indicated that a potential
function for PKCε might be to regulate quantitatively the
intracellular calcium signal initiated by PGF2α on one of
its luteal targets, the steroidogenic cells. The present stud-
ies validate the effective and specific down-regulation of
PKCε by siRNA technology and provide strong evidence
about the function of this PKC isozyme in luteal physiol-
ogy. The data support the overall hypothesis that down-
regulating expression of PKCε reduces the effectiveness of
PGF2α in reducing progesterone synthesis/secretion. This
observation extends the report that when PKCε was inhib-
PKCα and PKCβII protein after 96 h transfection of luteal steroidogenic cells with PKCε specific siRNAFigure 3
PKCα and PKCβII protein after 96 h transfection of luteal steroidogenic cells with PKCε specific siRNA. (A) Representative 
Western blot showing the amount of PKCα, PKCβII KCε and actin detected in protein samples prepared from luteal ster-
oidogenic cells after 96 h of transfection with PKCε specific siRNA (lane 1). Lanes labeled 2 – 4, contained protein samples 
from indicated control treatments (media, Non-sp siRNA, and transfection reagent, respectively. B and C) Semi-quantitative 
analysis of the densitometry derived from four experiments similar to the one shown in panel A for PKCα (B) and PKCβII (C). 
The y-axis shows the ratio of the optical density ratio of PKC isozyme to that of its corresponding β-actin. The data are shown 
as mean ± SEM, and comparisons were made between different treatments by one-way ANOVA followed by Tukey-Kramer 
honestly significant difference.
Reproductive Biology and Endocrinology 2007, 5:37 http://www.rbej.com/content/5/1/37
Page 9 of 13
(page number not for citation purposes)
ited with PKCε-specific inhibitors, the PGF2α – induced
rise in [Ca2+]i was decreased in LLC and SLC and that this
in turn had consequences (at least in part) in the ability of
PGF2α to inhibit LH-stimulated P4 secretion at this devel-
opmental stage [27]. As previously reported [17], LH
induced an increase in the amount of P4 secretion. Inter-
estingly, in the group where PKCε expression was down -
regulated, the inhibitory effect of PGF2α on LH-stimu-
lated P4 secretion was significantly mitigated (Fig. 3). This
observation has an important physiological corollary:
both PGF2α-receptors and PKCε are expressed in the same
luteal cell type. Therefore, the isozyme PKCε has an
important compatible time (mid-luteal phase) and place
(small and large luteal steroidogenic cells) of expression,
for it to have a role in the luteal transition from resistance
to sensitivity to luteolytic actions of PGF2α. Furthermore,
if PKCε expression is down -regulated (this study) or if its
activation is inhibited [27], the anti-steroidogenic effect of
PGF2α on LH-stimulated P4 secretion is impaired.
Experiment 2 also tested the hypothesis that down-regu-
lating PKCε could influence the expression of key PG
metabolizing enzymes that, in turn, could influence the
balance of PG production from luteo-protective or luteo-
trophic to luteolytic. The mechanism for luteal resistance
is not exactly known. However there is now evidence that
regulation of key PG metabolizing enzymes observed dur-
ing physiological states in which the life span of the CL is
modified is likely to play an important role in this com-
plex process [41-49]. The selection of the examined genes
was based on the available evidence that, because of their
key positions in the PG biosynthetic pathway, these genes
have been shown to determine the accumulation of lute-
olytic or luteotrophic classes of PG [40-45]. For example,
we examined the effects of down-regulating PKCε on the
expression of PGE2 and F synthases because of their more
direct effect on determining whether PGH2 is metabo-
lized to PGE2 or PGF2α. The results obtained were unex-
pected; the prediction was that because of low expression
of PKCε, exogenous PGF2α would not be able to induce
high increases in the cytosolic concentration of calcium,
and consequently, the expression of PGE2 synthase/PGF2α
synthase ratio would favor PGE2 synthesis. The above con-
ditions would favor luteal function. However, it is worth
pointing out the importance of looking beyond steady
states of mRNA encoding these enzymes; sometimes regu-
lation may be at the level of protein or even enzyme activ-
ity and additional work is necessary before rejecting the
tested hypothesis.
The developmental significance of a regulatory role
played by cytosolic calcium concentrations in mediating
the inhibitory actions of PGF2α is documented by results
obtained in experiment 3. As reported in previous studies
[17], PGF2α reduced LH-stimulated P4 secretion in Day-
10 cells only. Basal P4 secretion was not affected by the
PGF2α-treatment at any of the two developmental stages
tested. As the working hypothesis predicted, the pharma-
cological increase in [Ca2+]i induced by A23187 effec-
tively mimicked the inhibitory effect of PGF2α in Day -10
steroidogenic cells. Furthermore, as predicted by the
working hypothesis, the A23187 treatment also inhibited
LH-stimulated P4 secretion in Day -4 steroidogenic cells.
This inhibitory effect of A23187 is most likely due to its
demonstrated effect in increasing the intracellular concen-
tration of calcium ions [27] in these cells and not due to
other non-specific effects. This interpretation is also sup-
ported by the observation that treatment with A23187
had no negative effect on basal P4 secretion at any of the
two developmental stages tested.
Further support for the significance of a regulatory role
played by the increase in [Ca2+]i in mediating the inhibi-
tory actions of PGF2α is documented by results obtained
in experiment 3 where the cytoplasmic calcium buffering
capacity of the cells was increased by Bapta-AM. At lower
concentrations (0.1 and 1.0 µmol), the calcium buffering
capacity of Bapta-AM was, most likely, at values that still
allowed a PGF2α-stimulated increase in [Ca2+]i; which in
Effects of PKCε down-regulation on the ability of PGF2α to inhibit the LH-stimulated progesterone synthesis/secretion in cultures of steroidogenic l teal cells transfect d for 96 h withPKCε sp cific iRNA (filled bars) o  with transfection regents(con rol, open bars)Fig  4
Effects of PKCε down-regulation on the ability of PGF2α to 
inhibit the LH-stimulated progesterone synthesis/secretion in 
cultures of steroidogenic luteal cells transfected for 96 h with 
PKCε specific siRNA (filled bars) or with transfection regents 
(control, open bars). Progesterone accumulation was deter-
mined in culture media after 4 h of incubation in the follow-
ing treatments: LH (100 ng/ml), PGF2α (1 µg/ml) and a 
combination of PGF2α and LH. Data are presented as mean 
± SEM of four individual replicates (n = 4 cows). For each 
treatment group, statistical comparisons were made between 
PKCε down-regulated (PKCε siRNA) and control (not PKCε 
down-regulated); different letters above each SEM denote 
different values, P < 0.05.
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turn, preserved the ability of PGF2α to inhibit LH-stimu-
lated P4 secretion (Fig. 6). However, as the calcium buff-
ering capacity in the cytoplasm of the steroidogenic cells
was increased by increasing the concentration of Bapta-
AM (10 and 100 µmol), the calcium signaling feature of
activating the PGF2α receptors was most likely eliminated
or at least reduced, and consequently, the ability of PGF2α
to inhibit LH-stimulated P4 secretion was also signifi-
cantly reduced (Fig. 6). Similar effects of Bapta-AM on
basal and hormonal-stimulated steroidogenesis have
Effect of the Ca2+ ionophore, A23187, on basal and LH-stimulated progesterone synthesis/secretion (ng/ml) in cultured ster-oidogenic cells collected from Day 4 (pa el A) and Day 10 (pan l B) bovin  CLF gure 5
Effect of the Ca2+ ionophore, A23187, on basal and LH-stimulated progesterone synthesis/secretion (ng/ml) in cultured ster-
oidogenic cells collected from Day 4 (panel A) and Day 10 (panel B) bovine CL. Progesterone accumulated in culture media 
was determined after 4 h of incubation in the following treatments: media alone (Media), LH (100 ng/ml), LH and PGF2α (1000 
ng/ml), or LH and A23187 (0.1, 1, 10, and 100 µmol). As explained in Materials and Methods, these treatments also contained 
0.1% of the solvent used for PGF2α and A23187, DMSO. Data are presented as the mean ± SEM of four Day 4 and 10 Day 10 
individual replicates (n = 4 and 10 cows respectively). Statistical comparisons were made across treatments, and means with 
different letters, differ within each panel (P < 0.05).
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been reported in MA-10 Leydig cells (34). Therefore, the
results of experiment 3 stress the calcium requirement for
PGF2α to inhibit LH-stimulated P4 secretion in the mid-
phase CL and support the reported observation that the
lower efficacy of PGF2α to inhibit P4 secretion in the early
CL is related to the reduced ability of PGF2α to increase
the cytoplasmic concentration of calcium at this develop-
mental stage [17]. Taken together, the results obtained in
the A23187 and Bapta-AM experiments, strongly support
the proposed hypothesis that an attenuation of the luteo-
lytic actions of PGF2α is associated with a compromise in
the ability of PGF2α to induce a rise in [Ca2+]i [27]. There-
fore these studies provide a strong linkage between the
signal transduction utilized by the PGF2α receptor at dif-
ferent developmental stages and quantitative aspects of
the known intracellular mediator of PGF2α actions in the
CL, [Ca2+]i. In this regard, species differences do exist, as
in rat luteal cells the antigonadotropic action of PGF2α is
not mediated by elevated cytosolic calcium levels [50]. It
appears that the bovine CL therefore, has the following
commonalities with human CL: 1) in both species, PGF2α
is luteolysin, 2) the luteolytic effect of PGF2α appears only
during mid- and late-luteal phase, and 3) in both, the
humans and cows, changes in intracellular calcium
appear to regulate luteal function ([51] and this study).
In summary, the evidence presented here strongly sup-
ports the idea that PKCε, an isozyme highly expressed in
steroidogenic luteal cells with acquired luteolytic
response to PGF2α, has an important regulatory role in
the ability of PGF2α to inhibit LH-stimulated P4 secretion
in vitro at this developmental stage. The data presented
strongly support the hypothesis that luteal resistance to
the luteolytic actions of PGF2α is associated with a com-
promised ability of PGF2α to induce a rise in [Ca2+]i. If the
PGF2α receptor and its associated signal transduction is
bypassed with a pharmacological agent to increase the
[Ca2+]i, the LH-stimulated P4 secretion in Day -4 ster-
oidogenic cells is eliminated, an action that cannot be
induced by PGF2α at this developmental stage. Con-
versely, if the increase in [Ca2+]i typically induced by
PGF2α on Day-10 steroidogenic luteal cells is buffered by
Effect of the cell-permeable calcium chelator, Bapta-AM, on basal and LH-stimulated progesterone synthesis/secretion (ng/ml) in cultured steroidogenic cells ollected Day 10 bovine CLFig re 6
Effect of the cell-permeable calcium chelator, Bapta-AM, on basal and LH-stimulated progesterone synthesis/secretion (ng/ml) 
in cultured steroidogenic cells collected Day 10 bovine CL. Progesterone accumulated in culture media was determined after 4 
h of incubation in the following treatments: media alone (Media), LH (100 ng/ml), LH and PGF2α (1000 ng/ml), or LH and 
Bapta-AM (0.1, 1, 10, and 100 µmol). As explained in Materials and Methods, these treatments also contained 0.1% of the sol-
vent used for PGF2α and Bapta-AM, DMSO. Data are presented as the mean ± SEM of four Day 10 individual replicates (n = 4 
CL obtained from 4 cows). Statistical comparisons were made across treatments, and means with different letters denote dif-
ferent values, P < 0.05.
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a pharmacological agent, then the ability of PGF2α to
inhibit the LH-stimulated P4 secretion is abrogated.
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